967
Views
2
CrossRef citations to date
0
Altmetric
Original Article

In vivo effect of mouthwashes on viable viral load of SARS-CoV-2 in saliva: a pilot study

, , , , , , , , , , , , , ORCID Icon & show all
Article: 2198432 | Received 29 Dec 2022, Accepted 29 Mar 2023, Published online: 11 Apr 2023

References

  • COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins university (JHU) [Internet]. 2022 [cited 2022 Nov 10]. Available from: https://coronavirus.jhu.edu/map.html
  • Barrueco Á S, Mateos-Moreno MV, Martínez-Beneyto Y, et al. Effect of Oral Antiseptics in Reducing SARS-CoV-2 Infectivity: evidence from a Randomized Double-blind Clinical Trial. Emerg Microbes Infect. 2022 Jul 7;11(1):1–8. DOI:10.1080/22221751.2022.2098059
  • Azzi L, Carcano G, Gianfagna F, et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect. 2020 Jul;81(1):e45–50.
  • Pierri B, Tafuro M, Cuomo MC, et al. Assessment of Saliva Specimens’ Reliability for COVID-19 Surveillance. Front Public Health. 2022;10:840996.
  • Mateos-Moreno MV, Mira A, Ausina-Márquez V, et al. Oral antiseptics against coronavirus: in-vitro and clinical evidence. J Hosp Infect. 2021 Jul;113:30–43.
  • Xu C, Wang A, Hoskin ER, et al. Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity in vitro. Pathog Basel Switz. 2021 Mar 1;10(3):272. DOI:10.3390/pathogens10030272
  • Tadakamadla J, Boccalari E, Rathore V, et al. In vitro studies evaluating the efficacy of mouth rinses on Sars-Cov-2: a systematic review. J Infect Public Health. 2021 Sep;14(9):1179–1185.
  • Komine A, Yamaguchi E, Okamoto N, et al. Virucidal activity of oral care products against SARS-CoV-2 in vitro. J Oral Maxillofac Surg Med Pathol. 2021 Jul;33(4):475–477.
  • Muñoz-Basagoiti J, Perez-Zsolt D, León R, et al. Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants in vitro. J Dent Res. 2021 Oct;100(11):1265–1272.
  • Mezarina Mendoza JPI, Trelles Ubillús BP, Salcedo Bolívar GT, et al. Antiviral effect of mouthwashes against SARS-COV-2: a systematic review. Saudi Dent J. 2022 Mar;34(3):167–193.
  • Peng X, Xu X, Li Y, et al. Transmission routes of 2019-nCov and controls in dental practice. Int J Oral Sci. 2020 Mar 3;12(1):9.
  • de P EF, Corrêa L, Heller D, et al. Salivary SARS-CoV-2 load reduction with mouthwash use: a randomized pilot clinical trial. Heliyon. 2021 Jun;7(6):e07346.
  • Mira-Iglesias A, Mengual-Chuliá B, Cano L, et al. Retrospective screening for SARS-CoV-2 among influenza-like illness hospitalizations: 2018-2019 and 2019-2020 seasons, Valencia region, Spain. Influenza Other Respir Viruses. 2022 Jan;16(1):166–171.
  • R Core Team. R: a Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2020.
  • La Scola B, Le Bideau M, Andreani J, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis off Publ Eur Soc Clin Microbiol. 2020 Jun;39(6):1059–1061.
  • Burgos-Ramos E, Urbieta IR, Rodríguez D. Is hydrogen peroxide an effective mouthwash for reducing the viral load of SARS-CoV-2 in dental clinics? Saudi Dent J. 2022 Mar;34(3):237–242.
  • Gandhi G, Thimmappa L, Upadhya N, et al. Could mouth rinses be an adjuvant in the treatment of SARS‐CoV‐2 patients? An appraisal with a systematic review. Int J Dent Hyg. 2022 Feb;20(1):136–144.
  • Ferrer MD, Barrueco ÁS, Martinez-Beneyto Y, et al. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2. Sci Rep. 2021 Dec;11(1):24392.
  • Meister TL, Gottsauner JM, Schmidt B, et al. Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial. Virus Res. 2022 Jul 15;316:198791. DOI:10.1016/j.virusres.2022.198791
  • Alemany A, Perez-Zsolt D, Raïch-Regué D, et al. Cetylpyridinium chloride mouthwash to reduce shedding of Infectious SARS-CoV-2: a double-blind randomized clinical trial. J Dent Res. 2022 Nov;101(12):1450–1456.
  • Seneviratne CJ, Balan P, Kkk K, et al. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infection. 2021 Apr;49(2):305–311.
  • Huang YH, Huang JT. Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients. J Med Virol. 2021 Jul;93(7):4370–4373.
  • Costa DD, Brites C, Vaz SN, et al. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: a randomized clinical trial. Oral Dis. 2022 Nov;28 Suppl 2(S2):2500–2508.
  • Elzein R, Abdel-Sater F, Fakhreddine S, et al. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial. J Evid-Based Dent Pract. 2021 Sep;21(3):101584.
  • Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020 May;581(7809):465–469.
  • Gottsauner MJ, Michaelides I, Schmidt B, et al. A prospective clinical pilot study on the effects of a hydrogen peroxide mouth rinse on the intraoral viral load of SARS-CoV-2. Clin Oral Investig. 2020 Oct;24(10):3707–3713.
  • Bansal S, Jonsson CB, Taylor SL, et al. Iota-carrageenan and xylitol inhibit SARS-CoV-2 in vero cell culture. PLoS ONE. 2021;16(11):e0259943. DOI:10.1371/journal.pone.0259943
  • Cieplik F, Jakubovics NS. Preprocedural mouthwashes for reduction of SARS-CoV-2 viral load and infectivity. J Dent Res. 2022 Nov;101(12):1421–1423.